SURMOUNT-1 showed 19.5% average weight loss at this dose
Increased awareness, research, and conversations with trusted friends, family members, and medical professionals have made more people open to these medications, especially those with metabolic challenges
its about trust
Jay Campbell Partner Jay Campbell, partner, is a seasoned researcher with a 27-year tenure at Hart Research
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
You should consider reaching out (virtually or in person) if you have: Not had a bowel movement for more than 3 to 4 days Severe abdominal pain or distention Blood in your stool Constipation that significantly impacts quality of life Constipation that doesn't improve with your usual self-management strategies How pelvic floor physical therapy can help Pelvic floor physical therapy can be a very helpful tool when managing GLP-1-related constipation